Investigating the anti-tumoral effect of curcumin on the mice in which Ehrlich ascites and solid tumor is created

Publish Year: 1398
نوع سند: مقاله ژورنالی
زبان: English
View: 265

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-22-4_012

تاریخ نمایه سازی: 20 مهر 1398

Abstract:

Objective(s): In this study, the effects of different doses of curcumin application on Ehrlich ascites tumor (EAT) created in the mice of BALB/c type were investigated.Materials and Methods: Curcumin extracts can have hindering effect on tumor volume, vascular density, EAT cells around the tissues, and can support apoptosis. EAT cells (1x106) received from stock animals were injected intraperitoneally (IP) and subcutaneously (SC) to the animals. Then, curcumin was administered IP. Doses of 25 mg/kg IP and 50 mg/kg were administered over 10 days to the animals in the treatment groups in which ascites tumor was induced. The same doses were administered over 15 days in the treatment groups in which solid tumor was induced.Results: Histopathological examination in ascites tumor groups revealed that number of EAT cells at surrounding tissues was smaller in the group received 50 mg/kg curcumin when compared to tumor control group (P<0.05). The lowest increase in tumor volume was observed in the group received 25 mg/kg curcumin when compared to tumor control group (P<0.05). Conclusion: It was demonstrated once again in our study that curcumin had an anti-tumoral effect on both the development of ascites tumor created through EAT cells and the development of solid tumor.

Authors

Seher Yilmaz

Department of Anatomy, Yozgat Bozok University Faculty of Medicine, Yozgat, Turkey

Harun Ülger

Department of Anatomy, Erciyes University Faculty of Medicine, Kayseri, Turkey

Tolga Ertekin

Department of Anatomy, Kocatepe University Faculty of Medicine, Afyon, Turkey

Arzu Yay

Department of Histology, Embriology, Erciyes University Faculty of Medicine, Kayseri, Turkey

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Nisari M, Yilmaz S, Eroz R, Ertekin T, Bircan D, ...
  • Merlo LM, Pepper JW, Reid BJ. Cancer as an evolutionary ...
  • Gültekin M, Boztaş G: Breast cancer. T.C. Ministry of Health, ...
  • Odot J, Albert P, Carlıer A , Tarpın M, Devy ...
  • Ertekin T , Bozkurt O , Eroz R , Nisari ...
  • Akpolat M, Tarladaçalışır YT, Uz YH, Metin MS, Kızılay G. ...
  • Kocaaddam B, Şanlıer N. Curcumin, an active component of turmeric ...
  • Hatcher H, Planalp R, Cho J, Torti FM. Curcumin from ...
  • Ozaslan M, Karagoz I, Kilic I, Güldür M. Ehrlich ascites ...
  • Kaleoğlu Ö, İşli N. Ehrlich ascites tumour. Med J 1977; ...
  • O’Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, ...
  • Tozkoparan B, Aytaç SP. As a therapeutic target in cancer ...
  • Kızılcı S. Factors affecting the quality of life of cancer ...
  • Özkan S. Psycho-Oncology. Istanbul Form Advertisement Services 2007; 104-106. ...
  • Zeybek Ü. Cancer research and experimental models. J Exp Med ...
  • Sharma RA, Gescher AJ, Steward WP. Curcumin: the story so ...
  • Huang MT, Newmark HL, Frenkel K. Inhibitory effect of curcumin ...
  • Yu GW, Xu G, Ren JG, Xu X, Yuan HQ, ...
  • Ueki M, Ueno M, Morishita J, Maekava N. Curcumin ameliorates ...
  • Bhaumik S. Anjum R, Rangaraj N, Pardhasaradhi BV, Khar A. ...
  • Limtrakul P, Lipigorngoson S, Namwong O, Apisariyakul A, Dunn FW. ...
  • Armutak EI, Gültekin M. Effect of on apoptosis in vivo ...
  • Choudhuri T, Pal S, Agwarwal ML, Das T, Sa G. ...
  • Somasundaram S, Edmund NA, Moore DT, Small GW, Shi YY, ...
  • Weir NM, Selvendiran K, Kutula VK, Tong L, Vishwanath S, ...
  • Hlatky L, Hahnfeldt P, Folkman J. Clinical application of antiangiogenic ...
  • Yılmaz H, Ertekin T, Atay E, Nisari M, Güler SHAl ...
  • Delisser HM. Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J ...
  • Azab ME, Hishe H, Moustapha Y, Awady ES. Anti-angiogenic effect ...
  • Abuelba H, Cotrutz CE, Stoıca BA, Stoica L, Olınıcı D, ...
  • نمایش کامل مراجع